6-methylthiopurine has been researched along with Endometrial Neoplasms in 1 studies
6-methylthiopurine : A thiopurine that is 9H-purine substituted by a methylsulfanyl group at position 6.
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Presta, M | 1 |
| Rusnati, M | 1 |
| Belleri, M | 1 |
| Morbidelli, L | 1 |
| Ziche, M | 1 |
| Ribatti, D | 1 |
1 other study available for 6-methylthiopurine and Endometrial Neoplasms
| Article | Year |
|---|---|
Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.
Topics: 2-Aminopurine; Adenocarcinoma; Adenosine; Allantois; Animals; Antimetabolites, Antineoplastic; Antin | 1999 |